Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program
Pierre-Jean Pisella,1 Marc Labetoulle,2 Serge Doan,3 Beatrice Cochener-Lamard,4 Mourad Amrane,5 Dahlia Ismail,5 Catherine Creuzot-Garcher,6,7 Christophe Baudouin8–10 1Department of Ophthalmology, Tours University Hospital, University François Rabelais, Bretonneau Hospi...
Main Authors: | Pisella P, Labetoulle M, Doan S, Cochener-Lamard B, Amrane M, Ismail D, Creuzot-Garcher C, Baudouin C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-02-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/topical-ocular-01-cyclosporine-a-cationic-emulsion-in-dry-eye-disease--peer-reviewed-article-OPTH |
Similar Items
-
A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca
by: Jerkins GW, et al.
Published: (2020-02-01) -
A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
by: Periman LM, et al.
Published: (2020-12-01) -
Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
by: Burade V, et al.
Published: (2020-09-01) -
Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
by: de Oliveira RC, et al.
Published: (2019-07-01) -
Effect and Mechanisms of Medicinal Plants on Dry Eye Disease: A Systematic Review
by: Ezatollah Memarzadeh, et al.
Published: (2018-09-01)